• Joyce T Au, Joyce Wong, Arjun Mittra, Susanne Carpenter, Dana Haddad, Joshua Carson, Shiva Jayaraman, Sebastien Monette, Stephen B Solomon, Paula Ezell, and Yuman Fong.
• Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
• Surgery. 2011 Sep 1;150(3):474-9.

BackgroundReversible electroporation has long been used to transfer macromolecules into target cells in the laboratory by using an electric field to induce transient membrane permeability. Recently, the electric field has been modulated to produce permanent membrane permeability and cell death. This novel technique, irreversible electroporation (IRE), is being developed for nonthermal cancer ablation. We hypothesize that outside the central zone of IRE exists a peripheral zone of reversible electroporation where gene transfer may occur.MethodsIRE of the liver was performed in a Yorkshire pig model with administration of a plasmid expressing the marker gene green fluorescent protein (GFP) by bolus or primed infusion through the hepatic artery or portal vein. After 6 hours, livers were harvested for fluorescent microscopy and histologic examination.ResultsOf 36 liver specimens treated with IRE and the GFP plasmid, 31 demonstrated strong green fluorescence. Liver ablation by IRE was demarcated clearly on histology.ConclusionIRE is a promising technique not only for operative tissue ablation but also for gene therapy. Because IRE ablation may leave behind intact tumor antigens, these findings encourage clinical studies of tumor ablation with delivery of immunostimulatory plasmids for combined local eradication and systemic immunotherapy.Copyright © 2011. Published by Mosby, Inc.

21 keywords...

hide…